- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01417910
Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients
Prognostic Markers of Outcome in Patients Undergoing Infra-inguinal Revascularisation. A Prospective Observational Study.
Over 3000 people each year undergo bypass operations to their lower limbs, and these operations carry significant risks with approximately 1 in 20 of these people dying in hospital, and another 1 in 20 having a heart attack.
Assessment of these patients in order to stratify their risk of both dying and having significant complications aid in improving their care, enable better utilisation of scarce critical care resources, and allow us to give patients better information on which to base consent.
Aims The aims of the project are to assess the feasibility of exercise testing this group of patients both with cycle and arm exercise, and to identify markers of outcome in this group.
Methodology This is a prospective observational study designed to test the hypothesis that a combination of cardiopulmonary exercise testing and blood tests provides prognostic value on outcome measures after surgery for lower limb revascularisation
Subjects will have 2 exercise tests, one arm and one cycle, prior to surgery at their preoperative assessment appointment. From these tests we will measure how much work patients can do, how much oxygen they are able to use, and when the heart is unable to deliver enough oxygen to the cells. In addition they will have blood samples taken prior to the operation (brain natriuretic peptide), and on days 1 and 3 (troponin I) after the operation to look at cardiac markers of damage.
This data will be used to see if we can predict those patients that have both short and long term complications, and also to see whether the different forms of exercise testing are comparable, or if one type is superior.
Expected outcomes We expect that through a combination of exercise testing and blood test we will be able to identify patients at increased risk of complications after surgery. We also expect to find that arm exercise will be a more feasible and informative test that cycle exercise.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Background Over 3000 people each year undergo bypass operations to their lower limbs, and these operations carry significant risks with approximately 1 in 20 of these people dying in hospital, and another 1 in 20 having a heart attack. The number of people having this type of procedure has grown over recent years and the trend is predicted to continue. Due to this significant increase in the volume of these patients, and the associated complications that occur with this surgery, utilisation of more resources such as critical care is often needed.
Assessment of these patients in order to stratify their risk of both dying and having significant complications aid in improving their care, allow better utilisation of scarce critical care resources, and also allow us to provide patients with better information as part of the informed consent process.
A high risk group in major abdominal surgery can be identified through a simple exercise test (cardiopulmonary exercise test) that looks at how the body uses oxygen, and also through a blood test that look at a hormone secreted by the heart. Vascular surgical patients are at risk for the development of major cardiac complications in the postoperative period but a system for appropriate preoperative risk stratifications has yet to be achieved.
Aims The aims of the project are to assess the feasibility of exercise testing this group of patients both with cycle and arm exercise, and to identify markers of outcome in this group. Identification of markers that can predict how patients will fare after surgery will allow us to improve the informed consent process, utilise resources more effectively and efficiently and identify opportunities to attempt to modify outcomes.
Methodology This is a prospective observational study designed to test the hypothesis that a combination of cardiopulmonary exercise testing and blood tests provide prognostic value on outcome measures after surgery for lower limb revascularisation.
Participants will have 2 exercise tests, one arm and one cycle, prior to surgery at their preoperative assessment appointment. From these tests we will measure how much work patients can do, how much oxygen they are able to use, and when the heart is unable to deliver enough oxygen to the cells. In addition they will have blood samples taken prior to the operation (brain natriuretic peptide), and on days 1 and 3 (troponin I) after the operation to look at cardiac markers of damage.
This data will be used to see if we can predict those patients that have both short and long term complications, and also to see whether the different forms of exercise testing are comparable, or if one type is superior.
Expected outcomes We expect that through a combination of exercise testing and a blood test we will be able to identify patients at increased risk of complications after surgery. We also expect to find that arm exercise will be a more feasible and informative test that cycle exercise.
Implications Identification of a high risk group would allow appropriate strategies to be implemented to reduce risk, and allow better post-operative resource utilisation. This study will also allow a larger multicentre study to be adequately powered and constructed.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
North Yorkshire
-
York, North Yorkshire, Vereinigtes Königreich, YO318HE
- York Teaching Hospitals NHS Foundation Trust
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- All patients undergoing elective and expedited infra inguinal peripheral revascularisation. Patients undergoing radiological assessment (angiography) and/or radiological intervention for peripheral vascular disease
Exclusion Criteria:
- Patients refusing to participate in the study or unable to give informed consent.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Peripheral vascular disease
Subjects who have peripheral vascular disease
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
1 year all cause mortality
Zeitfenster: 1 year
|
1 year
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
1 year major adverse cardiac event.
Zeitfenster: 1 year
|
1 year
|
|
|
Morbidity as measured by the Post operative morbidity survey
Zeitfenster: 7 days
|
7 days
|
|
|
major adverse cardiac event.
Zeitfenster: participants will be followed for the duration of hospital stay, an expected median of 10 days
|
participants will be followed for the duration of hospital stay, an expected median of 10 days
|
|
|
30 day all cause mortality.
Zeitfenster: 30 day
|
30 day
|
|
|
Surgical post operative complications
Zeitfenster: participants will be followed for the duration of hospital stay, an expected median of 10 days
|
participants will be followed for the duration of hospital stay, an expected median of 10 days
|
participants will be followed for the duration of hospital stay, an expected median of 10 days
|
|
Medical post operative complications
Zeitfenster: participants will be followed for the duration of hospital stay, an expected median of 10 days
|
participants will be followed for the duration of hospital stay, an expected median of 10 days
|
participants will be followed for the duration of hospital stay, an expected median of 10 days
|
|
Quality of life measured at 6 and 12 months postoperatively by the EQ-5D-5L questionnaire.
Zeitfenster: 0,6 and 12 months
|
0,6 and 12 months
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Simon J Davies, MBChB, York Teaching Hospital NHS Foundation Trust
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- PVD10
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Gefäßerkrankungen
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Population Health Research Institute und andere MitarbeiterAktiv, nicht rekrutierendChirurgie (Herz) | Chirurgie (Major Vascular)Kanada, Vereinigtes Königreich
-
Azienda Ospedaliera Specializzata in Gastroenterologia...MedtronicNoch keine RekrutierungGAVE - Gastric Antral Vascular Ectasie
-
Assiut UniversityNoch keine RekrutierungGAVE - Gastric Antral Vascular Ectasie
-
Saint Camillus International University of Health...AbgeschlossenZufriedenheit, Patient | Bradykardie | Zufriedenheit, persönlich | Hypotonie während der Operation | Übelkeit/Erbrechen | Chirurgie (Major Vascular) | Entsättigung | Bluthochdruck arteriell | Fentanylanalgesie | Dexmedetomidin induzierte SedierungItalien
-
H. Lee Moffitt Cancer Center and Research InstituteColumbia University; University Hospitals Cleveland Medical Center; Geisinger... und andere MitarbeiterZurückgezogenBlutung | GAVE - Gastric Antral Vascular Ectasie | Blutender MagenVereinigte Staaten
-
Tianjin Huanhu HospitalAbgeschlossenBildauswertung | Endovaskuläre Thrombektomie | Fluid-attenuated Inversion Recovery Sequence Vascular Hyperintensity-Diffusion-Weighted Imaging Mismatch (FVH-DWI Mismatch)China